INP-12

N/A

Report date: 2024/09/24 20:00:05

Base Information

Drug NameINP-12
Drug Alias Namea nanoparticles-based oral paclitaxelINP12INP-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInnoup Farma Sl
China Registration ClassN/A

Develop Information

Active CompaniesInnoup Farma Sl
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A